Shifting Clinical Trial Endpoints in Kidney Transplantation: The Rise of Composite Endpoints and Machine Learning to...

Area of Science:

• Nephrology
• Transplantation Surgery
• Medical Statistics

Background:

• Kidney transplantation outcomes are meticulously tracked, surpassing most surgical procedures.
• Optimized immunosuppression has improved short- and long-term results.
• Outcome measures have shifted from traditional patient and graft survival to surrogate and composite endpoints.

Purpose of the Study:

• To review the evolution of outcomes measurement in kidney transplantation over the last two decades.
• To summarize recent advancements in clinical, histopathological, and immune outcomes assessment.
• To explore the application of composite endpoints, Bayesian concepts, and machine learning in refining prognostication.

Main Methods:

• Review of literature on kidney transplantation outcomes measurement over the past 20 years.
• Analysis of recent advances in clinical, histopathological, and immune outcome assessments.
• Discussion of composite endpoints, Bayesian statistics, and machine learning for prognostication.

Main Results:

• Outcomes measurement in kidney transplantation has become increasingly sophisticated.
• There has been a significant shift towards surrogate and composite endpoints.
• New methods integrate diverse data for refined risk prediction.

Conclusions:

• The field is moving towards more nuanced and predictive outcome measures in kidney transplantation.
• Advanced statistical and computational methods are crucial for future prognostication.
• Integrating clinical, histopathological, and immune data enhances predictive accuracy.